Ceritinib

Spécifications

1032900-25-6Numéro CAS

811-457-8Numéro CE

5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamineNom IUPAC

C28H36ClN5O3SFormule chimique

558.1 g/molMasse molaire

ceritinib; 1032900-25-6; LDK378; ZYKADIA; LDK-378; NVP-LDK378-NX; LDK 378; 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine; ceritinibum; K418KG2GET; NVP-LDK-378-NX; 5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine; CHEBI:78432; DTXSID10725373; 2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-; 5-Chloro-N2-(5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl)-N4-(2-(propane-2-sulfonyl)phenyl)pyrimidine-2,4-diamine; 5-chloro-N2-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-N4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine; RefChem:57924; DTXCID50676118; L01XE28; 811-457-8; Ceritinib (LDK378); 5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine; C28H36ClN5O3S; MFCD26142648; CHEMBL2403108; 4MK; 5-Chloro-N~2~-[5-Methyl-4-(Piperidin-4-Yl)-2-(Propan-2-Yloxy)phenyl]-N~4~-[2-(Propan-2-Ylsulfonyl)phenyl]pyrimidine-2,4-Diamine; 5-Chloro-N4-[2-[(1methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine;5-Chloro-N4-[2-[(1methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine; Ceritinib(LDK378); Ceritinib [USAN:INN]; UNII-K418KG2GET; Ceritinib[mi]; 2,4-Pyrimidinediamine, 5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-; 5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine; Ceritinib; LDK 378; Zykadia; Zykadia (TN); Ceritinib (Standard); Ceritinib; LDK378; LDK378(Ceritinib); CERITINIB [INN]; CERITINIB [JAN]; Eritinib (LDK378); CERITINIB [MI]; Ceritinib(LDK378)?; CERITINIB [USAN]; CERITINIB [VANDF]; CERITINIB [WHO-DD]; 5-Chloro-N2-[2-isopropoxy-5-Methyl-4-(4-piperidyl)phenyl]-N4-(2-isopropylsulfonylphenyl)pyriMidine-2,4-diaMine; Ceritinib (JAN/USAN/INN); CPD 15; GTPL7397; orb1227104; orb1307443; orb3141339; SCHEMBL1014329; CERITINIB [ORANGE BOOK]; SCHEMBL29349781; SCHEMBL29489147; EX-A187; VERWOWGGCGHDQE-UHFFFAOYSA-N; HMS3652H22; HMS3673I17; HMS3747A11; HMS5085F12; BDBM50436850; EBC-12909; HY-15656R; NSC776422; NSC777193; NSC800072; AKOS025396438; CCG-264762; CS-1406; DB09063; FC61431; GS-6356; NSC-776422; NSC-777193; NSC-800072; SB16490; compound 15b [PMID 23742252]; NCGC00351603-10; NCGC00351603-11; NCGC00351603-13; NCGC00351603-15; AC-27469; BP-43633; HY-15656; SY232206; L1340; NS00040660; S7083; SW219725-1; D10551; EN300-7404145; BRD-K22149900-001-01-3; BRD-K22149900-001-03-9; BRD-K22149900-001-05-4; Q21011233; Z2235802104; 5-chloro-2-N-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-4-N-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine; 5-chloro-N(2)-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N(4)-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine; 5-Chloro-N~2~-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N~4~-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine; 5-Chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine; 5-CHLORO-N2-(5-METHYL-4-(PIPERIDIN-4-YL)-2-(PROPAN-2-YLOXY)PHENYL)-N4-(2-(PROPANE-2- SULFONYL)PHENYL)PYRIMIDINE-2,4-DIAMINE; 5-Chloro-N2-[2-isopropoxy-5-methyl-4-(4-piperidinyl)phenyl]-N4-[2-(isopropylsulfonyl)phenyl]pyrimidine-2,4-diamine; 5-CHLORO-N4-(2-((1-METHYLETHYL)SULFONYL)PHENYL)-N2-(5-METHYL-2-(1-METHYLETHOXY)-4- (PIPERIDIN-4-YL)PHENYL)PYRIMIDINE-2,4-DIAMINE; N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamideSynonymes